highly significantP = 0.013
Two of the most striking findings were that (a) highly significant associations were discovered between the overexpression of HER2 (26/36 resistant patients, P = 0.013), KRAS (32/36 resistant patients, P = 0.004), low expression of PTEN (36/36 resistant patients, P = 0.043) and platinum resistance, and (b) platinum resistance ( P = 0.043), residual disease ( P < 0.001), the expression of VEGF ( P = 0.031) and HER2( P = 0.008), the expression of BRCA1( P = 0.05) and KRAS ( P = 0.021) were significantly associated with overall survival in patients with the same stages and treated with uniform therapies.